CD44 and hepatocellular carcinoma: A promising molecular target in hepatocellular carcinoma (HCC) is glypican-3 (GPC3), a cell-surface heparan sulfate proteoglycan that shows minimal expression in normal tissues but significant overexpression in 70–80% of HCC cases [60].